What is DNAnexus?
Founded in 2009 and headquartered in Mountain View, California, DNAnexus operates at the forefront of the bioinformatics industry. The company provides a secure and collaborative platform for accessing and utilizing biomedical data, catering to both internal teams and external collaborators. Its offerings span end-to-end diagnostic R&D and production bioinformatics platforms, supporting national biobank initiatives, and delivering multi-omics data science platforms for drug discovery to pharmaceutical companies. DNAnexus empowers the healthcare and life sciences sectors to transform their approach to biomedical data, thereby accelerating scientific breakthroughs and enhancing patient outcomes.
How much funding has DNAnexus raised?
DNAnexus has raised a total of $472.6M across 8 funding rounds:
Series B
$15M
Series C
$15M
Series D
$15M
Series E
$58M
Series F
$68M
Series G
$100M
Unspecified
$200M
Series B (2011): $15M led by TPG Biotech, Felicis Ventures, Google Ventures, First Round Capital, SoftTech VC, and K9 Ventures
Series C (2013): $15M supported by TPG Biotech, Claremont Creek Ventures, Google Ventures, and First Round Capital
Series D (2015): $15M featuring WuXi AppTec
Series E (2018): $58M backed by Claremont Creek Ventures, MidCap Financial, WuXi NextCODE, Google Ventures, TPG Biotech, Microsoft, and Foresite Capital
Series F (2019): $68M with participation from WuXi NextCODE, Foresite Capital, Innovatus Capital Partners, TPG Biotech, GV, and Claremont Creek Ventures
Series G (2020): $100M led by Perceptive Advisors LLC, Northpond Ventures LLC, Google Ventures, Regeneron Pharmaceuticals , Inc., First Round Capital, Foresite Capital, and Texas Pacific Group
Unspecified (2022): $200M supported by Innovatus Capital Partners, Perceptive Advisors, Foresite Capital, Blackstone Accelerates Growth, Northpond Ventures, and GV
Key Investors in DNAnexus
Innovatus Capital Partners
Innovatus Capital Partners specializes in long-term capital investments across various asset classes, focusing on opportunities created by market volatility and disruptions. The firm targets asset-based investments with strong cash flow, particularly in areas where value is misunderstood or mispriced.
Perceptive Advisors
Perceptive Advisors is an investment firm focused on funding innovative healthcare and life sciences technologies. They manage significant assets and are known for their strategic investments in the sector.
Google Ventures
GV is a venture capital firm that invests across multiple stages and sectors, with a particular focus on enterprise solutions and life sciences. They provide financial backing to promising startups and growth-stage businesses globally.
What's next for DNAnexus?
The significant capital raised by DNAnexus, particularly the recent strategic investment, positions the company for accelerated expansion and innovation. This influx of financing is expected to fuel further development of its bioinformatics platform, enhance its capabilities in handling large-scale biomedical datasets, and broaden its market reach within the healthcare and life sciences industries. The company is likely to focus on strengthening its collaborative tools and data security features, further solidifying its role as a critical enabler of precision medicine and drug discovery.
See full DNAnexus company page
